Abstract
Purpose
The purpose of the study was to investigate the impact of a family history (FH) of colorectal cancer (CRC) in first-degree relatives on the outcome of patients with CRC in a veterans’ hospital in Taiwan.
Methods
Patients (N = 3,383) with colorectal adenocarcinoma were studied; pedigrees were collected prospectively. Associations between FH and clinicopathologic variables were analyzed using linear-by-linear association. Survival was examined with Kaplan–Meier curves and the log-rank test.
Results
Two hundred ninety-seven patients (8.78%) had a first-degree relative with CRC. The average age of onset of CRC was 68.3 years in patients without a FH. This was significantly higher than the age of onset in patients with a FH (66.4 years—one first-degree relative with CRC; 48.8 years—two or more first-degree relatives, P < 0.001). Patients with more affected family members had a higher incidence of right-sided tumor (P = 0.004), metachronous cancer (P = 0.034), and less-advanced disease (P = 0.044). The 5-year overall survival was 83% for patients with two or more first-degree relatives with CRC, 57% for those with one first-degree relative, and 55% for those without a FH (P = 0.001). The 5-year DFS was 91% for patients with two or more first-degree relatives, 66% for those with one first-degree relative, and 64% for those without a FH of CRC (P = 0.002). In the multivariate analysis, TNM stage played the most independent prognostic factor, followed by FH (P < 0.001, hazard ratio = 1.52; 95% confidence interval, 1.24–1.85).
Conclusions
CRC patients with a family history of CRC had better survival than did those without a family history of CRC.
Similar content being viewed by others
Abbreviations
- FH:
-
family history
- CRC:
-
colorectal cancer
- DFS:
-
disease-free survival
References
Little J, Faivre J (1999) Family history, metabolic gene polymorphism, diet and risk of colorectal cancer. Eur J Cancer Prev 8(Suppl 1):s61–72
Jass JR (2000) Familial colorectal cancer: pathology and molecular characteristics. Lancet Oncol 1:220–226
Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851–1860
Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J (1994) Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 3:121–125
Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348:919–932
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC (1994) A prospective study of family history and the risk colorectal cancer. N Engl J Med 331:1669–1674
Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, Kinmonth AL (2007) The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 97:486–493
Johns LE, Houlston RS (2001) A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96:2992–3003
Bertario L, Aste H, Arrigoni A, Fracasso P, Rossini FP, Rossetti C, Valanzano R (1996) Clinical aspects and management of hereditary non-polyposis colorectal cancer (HNPCC). Tumori 82:117–121
Desai TK, Barkel D (2008) Syndromic colon cancer: Lynch syndrome and famililal adenomatous polyposis. Gastroenterol Clin North Am. 37:47–72
Giráldez MD, Castellví-Bel S, Balaguer F, Gonzalo V, Ocaña T, Castells A (2008) Lynch syndrome in colorectal cancer patients. Expert Review of Anticancer Therapy 8:573–583
Gatalica Z, Torlakovic E (2008) Pathology of the hereditary colorectal cancer. Familial Cancer 7:15–26
Sankila R, Järvinen ALA, HJ MJP (1996) Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 110:682–687
Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342:69–77
Benatti P, Gafa R, Barana D, Marino M, Scarselli A, Pedroni M, Maestri I, Guerzoni L, Roncucci L, Menigatti M, Roncari B, Maffei S, Rossi G, Ponti G, Santini A, Losi L, Di Gregorio C, Oliani C, Ponz de Leon M, Lanza G (2005) Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res 11:8332–8340
Lukish JR, Muro K, DeNobile J, Katz R, Williams J, Cruess DF, Drucker W, Kirsch I, Hamilton SR (1998) Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 227:51–56
Slattery ML, Kerber RA (1995) The impact of family history of colon cancer on survival after diagnosis with colon cancer. Int J Epidemiol 24:888–896
Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Schaefer P, Whittom R, Hantel A, Goldberg RM, Warren RS, Bertagnolli M, Fuchs CS (2008) Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA 299:2515–2523
Aste H, Picasso M, Allegretti A, Conio M (1994) Correlation between family history of colorectal cancer and pathological and clinical features of the disease. Cancer Detect Prev 18:343–348
Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Path Lab Med 124:979–994
Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS (2008) Family history and survival after colorectal cancer diagnosis. Cancer 112:1222–1229
Committee R (1993) Japanese Research Society for Cancer of the Colon and Rectum. Clinical and pathological analyses of patients with a family history of colorectal cancer. Jpn J Clin Oncol 23:342–349
King-Yin Lam A, Ong K, Ho YH (2006) Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum 49:1275–1283
Ramsey SD, Yoon P, Moonesinghe R, Khoury MJ (2006) Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 8:571–575
Woods SE, Narayanan K, Engel A (2005) The influence of gender on colon cancer stage. J Womens Health (Larchmt) 14:502–506
Acknowledgments
The authors would like to acknowledge the kind assistance of Nurse Wen-Chien Sung, Nurse Jihn-Yi Shy, and Nurse Ching-Ju Yang who performed the patient interviews.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kao, PS., Lin, JK., Wang, HS. et al. The impact of family history on the outcome of patients with colorectal cancer in a veterans’ hospital. Int J Colorectal Dis 24, 1249–1254 (2009). https://doi.org/10.1007/s00384-009-0774-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-009-0774-3